title: Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.
authors.affiliation: Department of Internal Medicine, University of Genoa, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Furnari
authors.forename: A
authors.initials: A
authors.lastname: Parodi
authors.forename: L
authors.initials: L
authors.lastname: Gemignani
authors.forename: E G
authors.initials: EG
authors.lastname: Giannini
authors.forename: S
authors.initials: S
authors.lastname: Marenco
authors.forename: E
authors.initials: E
authors.lastname: Savarino
authors.forename: L
authors.initials: L
authors.lastname: Assandri
authors.forename: V
authors.initials: V
authors.lastname: Fazio
authors.forename: D
authors.initials: D
authors.lastname: Bonfanti
authors.forename: S
authors.initials: S
authors.lastname: Inferrera
authors.forename: V
authors.initials: V
authors.lastname: Savarino